National Eye Institute
Xuri Li has not added Biography.
If you are Xuri Li and would like to personalize this page please email our Author Liaison for assistance.
Expression of a novel PDGF isoform, PDGF-C, in normal and diseased rat kidney.
Journal of the American Society of Nephrology : JASN Apr, 2002 | Pubmed ID: 11912250
Angiogenesis stimulated by PDGF-CC, a novel member in the PDGF family, involves activation of PDGFR-alphaalpha and -alphabeta receptors.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology Oct, 2002 | Pubmed ID: 12374780
PDGF-D is a potent transforming and angiogenic growth factor.
Oncogene Mar, 2003 | Pubmed ID: 12629513
Novel PDGF family members: PDGF-C and PDGF-D.
Cytokine & growth factor reviews Apr, 2003 | Pubmed ID: 12651221
Transgenic overexpression of platelet-derived growth factor-C in the mouse heart induces cardiac fibrosis, hypertrophy, and dilated cardiomyopathy.
The American journal of pathology Aug, 2003 | Pubmed ID: 12875986
Tissue plasminogen activator is a potent activator of PDGF-CC.
The EMBO journal Oct, 2004 | Pubmed ID: 15372073
Revascularization of ischemic tissues by PDGF-CC via effects on endothelial cells and their progenitors.
The Journal of clinical investigation Jan, 2005 | Pubmed ID: 15630451
VEGF-B inhibits apoptosis via VEGFR-1-mediated suppression of the expression of BH3-only protein genes in mice and rats.
The Journal of clinical investigation Mar, 2008 | Pubmed ID: 18259607
Reevaluation of the role of VEGF-B suggests a restricted role in the revascularization of the ischemic myocardium.
Arteriosclerosis, thrombosis, and vascular biology Sep, 2008 | Pubmed ID: 18511699
Paracrine signaling by platelet-derived growth factor-CC promotes tumor growth by recruitment of cancer-associated fibroblasts.
Cancer research Jan, 2009 | Pubmed ID: 19118022
A role for a CXCR2/phosphatidylinositol 3-kinase gamma signaling axis in acute and chronic vascular permeability.
Molecular and cellular biology May, 2009 | Pubmed ID: 19255141
VEGF-B is dispensable for blood vessel growth but critical for their survival, and VEGF-B targeting inhibits pathological angiogenesis.
Proceedings of the National Academy of Sciences of the United States of America Apr, 2009 | Pubmed ID: 19369214
VEGF-B: a survival, or an angiogenic factor?
Cell adhesion & migration Oct-Dec, 2009 | Pubmed ID: 19684473
Platelet-derived growth factor-DD targeting arrests pathological angiogenesis by modulating glycogen synthase kinase-3beta phosphorylation.
The Journal of biological chemistry May, 2010 | Pubmed ID: 20231273
Survival effect of PDGF-CC rescues neurons from apoptosis in both brain and retina by regulating GSK3beta phosphorylation.
The Journal of experimental medicine Apr, 2010 | Pubmed ID: 20231377
Semaphorin 3E initiates antiangiogenic signaling through plexin D1 by regulating Arf6 and R-Ras.
Molecular and cellular biology Jun, 2010 | Pubmed ID: 20385769
VEGF-B: a thing of beauty.
Cell research Jul, 2010 | Pubmed ID: 20531376
PDGF-CC blockade inhibits pathological angiogenesis by acting on multiple cellular and molecular targets.
Proceedings of the National Academy of Sciences of the United States of America Jul, 2010 | Pubmed ID: 20566880
Oligo-guanosine nucleotide induces neuropilin-1 internalization in endothelial cells and inhibits angiogenesis.
Blood Oct, 2010 | Pubmed ID: 20606164
Complement-mediated inhibition of neovascularization reveals a point of convergence between innate immunity and angiogenesis.
Blood Nov, 2010 | Pubmed ID: 20625009
VEGF-independent angiogenic pathways induced by PDGF-C.
Oncotarget Aug, 2010 | Pubmed ID: 20871734
Complicated life, complicated VEGF-B.
Trends in molecular medicine Feb, 2012 | Pubmed ID: 22178229
Targeting of junctional adhesion molecule-C (JAM-C) inhibits experimental choroidal neovascularization.
Investigative ophthalmology & visual science Feb, 2012 | Pubmed ID: 22323465